News

2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

Should You Invest in This Under-the-Radar Weight Loss Stock?

If you're interested in capitalizing on the rapidly growing weight management market, you might naturally consider investing in Eli Lilly and Novo Nordisk. That's not a bad strategy since these two ...